Should we use closed or open infusion containers for prevention of bloodstream infections?

Annals of Clinical Microbiology and Antimicrobials

Volumn 9, Issue , 2010, Pages

  Rangel Frausto, Manuel S ^a   Higuera Ramirez, Francisco ^b   Martinez Soto, Jose ^a   Rosenthal, Victor D ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c Medical College of Buenos Aires   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM ISOLATE; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; CLOSED INFUSION CONTAINER; CONTAINER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HYGIENE; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEXICO; MICROBIAL CONTAMINATION; MORTALITY; OPEN INFUSION CONTAINER; PROSPECTIVE STUDY; SEQUENTIAL ANALYSIS; BACTEREMIA; COHORT ANALYSIS; DRUG PACKAGING;

ADULT; BACTEREMIA; COHORT STUDIES; DRUG PACKAGING; HUMANS; INTENSIVE CARE UNITS; MEXICO; PROSPECTIVE STUDIES;

EID: 77649150243     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-9-6     Document Type: Article

References (43)

1. Crnich CJ, Maki DG. The Role of Intravascular Devices in Sepsis. Curr Infect Dis Rep 2001, 3(6):496-506. 10.1007/s11908-001-0086-4, 11722805.
2. Higuera F, Rangel-Frausto MS, Rosenthal VD, Soto JM, Castanon J, Franco G, Tabal-Galan N, Ruiz J, Duarte P, Graves N. Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 2007, 28(1):31-35. 10.1086/510812, 17315338.
3. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis. Am J Infect Control 2003, 31(8):475-480. 10.1016/j.ajic.2003.03.002, 14647110.
4. Ramirez Barba EJ, Rosenthal VD, Higuera F, Oropeza MS, Hernandez HT, Lopez MS, Lona EL, Duarte P, Ruiz J, Hernandez RR, et al. Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control 2006, 34(4):244-247. 10.1016/j.ajic.2005.05.024, 16679185.
5. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, Cuellar LE, Arikan OA, Abouqal R, Leblebicioglu H. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006, 145(8):582-591.
6. Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F, Cuellar LE, Madani N, Mitrev Z, Duenas L, et al. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control 2008, 36(9):627-637. 10.1016/j.ajic.2008.03.003, 18834725.
7. Lynch P, Rosenthal VD, Borg MA, Eremin SR. Infection Control: A Global View. 2008, 255-271. Bennett and Brachman's Hospital Infections, San Francisco, California, Lippincott, Williams, and Wilkins, Jarvis WR.
8. Mehta A, Rosenthal VD, Mehta Y, Chakravarthy M, Todi SK, Sen N, Sahu S, Gopinath R, Rodrigues C, Kapoor P, et al. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007, 67(2):168-174. 10.1016/j.jhin.2007.07.008, 17905477.
9. Leblebicioglu H, Rosenthal VD, Arikan OA, Ozgultekin A, Yalcin AN, Koksal I, Usluer G, Sardan YC, Ulusoy S. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007, 65(3):251-257. 10.1016/j.jhin.2006.10.012, 17257710.
10. Moreno CA, Rosenthal VD, Olarte N, Gomez WV, Sussmann O, Agudelo JG, Rojas C, Osorio L, Linares C, Valderrama A, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 2006, 27(4):349-356. 10.1086/503341, 16622811.
11. Rosenthal VD, Guzman S, Crnich C. Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol 2004, 25(3):251-255. 10.1086/502386, 15061418.
12. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003, 31(5):291-295. 10.1067/mic.2003.1, 12888765.
13. Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, Castaneda-Sabogal A, Rosales R, Mayorga-Espichan MJ, Camacho-Cosavalente LA, Castillo-Bravo LI. Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica 2008, 24(1):16-24. 10.1590/S1020-49892008000700002, 18764990.
14. Salomao R, Rosenthal VD, Grimberg G, Nouer S, Blecher S, Buchner-Ferreira S, Vianna R, Maretti-da-Silva MA. Device-associated infection rates in intensive care units of Brazilian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica 2008, 24(3):195-202. 10.1590/S1020-49892008000900006, 19115547.
15. Macias AE, Munoz JM, Bruckner DA, Galvan A, Rodriguez AB, Guerrero FJ, Medina H, Gallaga JC, Cortes G. Parenteral infusions bacterial contamination in a multi-institutional survey in Mexico: considerations for nosocomial mortality. Am J Infect Control 1999, 27(3):285-290. 10.1053/ic.1999.v27.a92879, 10358234.
16. Maki DG, Anderson RL, Shulman JA. In-use contamination of intravenous infusion fluid. Appl Microbiol 1974, 28(5):778-784. 186824, 4613269.
17. Rosenthal VD, Maki DG. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia. Am J Infect Control 2004, 32(3):135-141. 10.1016/j.ajic.2003.12.002, 15153924.
18. Epstein SE. Cost-effective application of the Centers for Disease Control Guideline for Prevention of Catheter-associated Urinary Tract Infections. Am J Infect Control 1985, 13(6):272-275. 10.1016/0196-6553(85)90028-8, 3002212.
19. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004, 53(RR-3):1-36.
20. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999, 27(2):97-132. quiz 133-134; discussion 196, 10.1016/S0196-6553(99)70088-X, 10196487.
21. Maki DG, Rhame FS, Mackel DC, Bennett JV. Nationwide epidemic of septicemia caused by contaminated intravenous products. I. Epidemiologic and clinical features. Am J Med 1976, 60(4):471-485. 10.1016/0002-9343(76)90713-0, 1274981.
22. Goldmann DA, Dixon RE, Fulkerson CC, Maki DG, Martin SM, Bennett JV. The role of nationwide nosocomial infection surveillance in detecting epidemic bacteremia due to contaminated intravenous fluids. Am J Epidemiol 1978, 108(3):207-213.
23. Munoz JM, Macias AE, Guerrero FJ, Hernandez I, Medina H, Vargas E. [Control of pediatric nosocomial bacteremia by a program based on culturing of parenteral solutions in use]. Salud Publica Mex 1999, 41(Suppl 1):S32-37.
24. Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications--Brazil, 1996. MMWR Morb Mortal Wkly Rep 1998, 47(29):610-612.
25. Matsaniotis NS, Syriopoulou VP, Theodoridou MC, Tzanetou KG, Mostrou GI. Enterobacter sepsis in infants and children due to contaminated intravenous fluids. Infect Control 1984, 5(10):471-477.
26. Macias AE, de Leon SP, Huertas M, Maravilla E, Romero C, Montoya TG, Munoz JM, Lopez-Vidal Y. Endemic infusate contamination and related bacteremia. Am J Infect Control 2008, 36(1):48-53. 10.1016/j.ajic.2007.02.003, 18241736.
27. Kilian J, Hosch A, Ahnefeld FW, Schmitz JE, Vanek E. [Bacterial contamination as a complication of intravenous therapy in intensive care (author's transl)]. Anaesthesist 1980, 29(10):559-566.
28. McAllister JC, Buchanan EC, Skolaut MW. A comparison of the safety and efficiency of three intermittent intravenous therapy systems--the minibottle, the minibag and the inline burette. Am J Hosp Pharm 1974, 31(10):961-967.
29. Scheckler WE, Brimhall D, Buck AS, Farr BM, Friedman C, Garibaldi RA, Gross PA, Harris JA, Hierholzer WJ, Martone WJ, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1998, 19(2):114-124. 10.1086/647779, 9510112.
30. Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR, Banerjee S, Edwards JR, Martone WJ, Gaynes RP, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991, 19(1):19-35. 10.1016/0196-6553(91)90157-8, 1850582.
31. Balows A, Hausler W, Shadomy H. Manual of Clinical Microbiology 1991, Washington DC, American Society of Microbiology, 5.
32. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16(3):128-140. 10.1016/0196-6553(88)90053-3, 2841893.
33. Rosenthal VD, McCormick RD, Guzman S, Villamayor C, Orellano PW. Effect of education and performance feedback on handwashing: the benefit of administrative support in Argentinean hospitals. Am J Infect Control 2003, 31(2):85-92. 10.1067/mic.2003.63, 12665741.
34. Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003, 31(7):405-409. 10.1067/mic.2003.52, 14639436.
35. Higuera F, Rosenthal VD, Duarte P, Ruiz J, Franco G, Safdar N. The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico. Crit Care Med 2005, 33(9):2022-2027. 10.1097/01.CCM.0000178190.89663.E5, 16148475.
36. Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control 2005, 33(9):501-509. 10.1016/j.ajic.2005.04.246, 16260325.
37. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994, 161(6):374-378.
38. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271(20):1598-1601. 10.1001/jama.271.20.1598, 8182812.
39. Heiselman D. Nosocomial bloodstream infections in the critically ill. JAMA 1994, 272(23):1819-1820. 10.1001/jama.272.23.1819, 7990208.
40. Jarvis WR. The evolving world of healthcare-associated bloodstream infection surveillance and prevention: is your system as good as you think?. Infect Control Hosp Epidemiol 2002, 23(5):236-238. 10.1086/502041, 12026146.
41. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994, 15(4 Pt 1):231-238. 10.1086/646902, 8207189.
42. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002, 51(RR-10):1-29.
43. Maki D, Mermel L, Bennett JV. Infections due to infusion therapy. Hospital Infections 1998, Philadelphia: Lippincott-Raven, Brachman PS, Fourth.